CAPITAL INSURANCE GROUP RECOGNIZED IN 2025 AMERICAN BUSINESS AWARDS®
MONTEREY, Calif., May 21, 2025 /PRNewswire/ -- Capital Insurance Group® (CIG®), a leading regional property and casualty insurer in the Western U.S., is proud to announce multiple teams within the company have been selected as honorees in separate categories for the 23rd Annual American Business Awards ®.
Capital Insurance Group was awarded a Gold Stevie® Award in the Company of the Year - Insurance – Large category. Additionally, two teams were recognized as Teams of the Year with the Development Team taking home a Gold Stevie® Award for Technology Team of the Year, and the Communications Team receiving a Silver Stevie® Award. Judges had high praise for CIG, remarking on their resilience, ability to expand products, continued attainment of financial metrics, and noted the company successfully attracted and retained customers amid tough regulatory challenges. CIG was recognized for its customer-focused approach which yields high retention and glowing customer testimonials.
CIG's IT Development team was recognized for their innovation, resilience, and impact on the company through major system upgrades, cloud migrations, and enhanced quoting tools. The result of their cross-functional collaboration and efforts was improved agent transparency, operational efficiency, and improved customer experience.
Judges celebrated CIG's Communications team for their strategic approach, measurable results, and impressive nature of accomplishments, especially given their size. Also noteworthy was the team's ability to overcome challenges, demonstrating agility, creativity, and operational excellence with demonstrable strategic impact.
At Capital Insurance Group, a strong commitment to open and transparent communication shapes the company's culture and drives success. Guided by CIG's core values that serve as the foundation of its operations, the CIG team works collaboratively to deliver results and do what's right. The company embraces a thoughtful, measured approach to decision-making, reflected in the guiding principle "measure twice; cut once," a reminder shared across CIG to prioritize integrity and excellence in everything they do.
CIG President & CEO, Andy Doll reflected on the awards: "Everyone at CIG has been working hard for a long time, and those efforts have been reflected in our results. These awards illustrate how this hard work is being recognized by those independent from the company. This adds greater credibility and value of every CIG employee's effort."
The Stevie® Awards, established in 2002, honor organizations and professionals globally for their achievements. The American Business Awards® accept nominations from all U.S. organizations across various categories. This year, over 3,600 nominations were submitted by organizations of all sizes, judged by more than 250 professionals worldwide to determine the winners. More details and the 2025 Stevie winners list can be found at www.StevieAwards.com/ABA.
About Capital Insurance Group
Established in 1898, Capital Insurance Group® (CIG®) is a leading regional property and casualty insurer in the Western U.S. CIG offers trusted Agriculture, Commercial, and Personal coverage across Arizona, California, Nevada, Oregon, and Washington.
Known for superior customer service and customizable coverage, CIG delivers insurance solutions tailored to meet the needs of policyholders, sold exclusively through independent agents. CIG's suite of insurance offerings include coverage for Homeowners, Renters, Personal Auto, Dwelling Fire, Businessowners, Commercial Auto, Farm Owners, Commercial Agriculture, Farm Auto, Commercial Real Estate, and more. Throughout its footprint, CIG partners with regional and local charitable organizations and events to give back to communities in ways that promote preparedness, enhance resilience, and bring relief to communities in crisis.
CIG is underwritten by its affiliate companies: California Capital Insurance Company, Eagle West Insurance Company, Nevada Capital Insurance Company, and Monterey Insurance Company. CIG is rated "A" (Excellent) by AM Best, the independent financial monitor of the insurance industry and is proud to be part of the Auto-Owners Insurance group of companies, one of the nation's largest, most-trusted insurers. For more information, please visit CIGInsurance.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/capital-insurance-group-recognized-in-2025-american-business-awards-302462187.html
SOURCE Capital Insurance Group
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
9 hours ago
- Business Upturn
HIMS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Hims & Hers Health, Inc. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partners Brandon Walker and Marion Passmore Encourage Investors Who Suffered Losses In Hims To Contact Them To Discuss Their Options If you purchased or acquired securities in Hims between April 29, 2025 and June 23, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. NEW YORK, Aug. 02, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. ('Hims & Hers' or the 'Company') (NYSE:HIMS) in the United States District Court for the Northern District of California on behalf of all persons and entities who purchased or otherwise acquired Hims securities between April 29, 2025 and June 23, 2025, both dates inclusive (the 'Class Period'). Investors have until August 25, 2025 to apply to the Court to be appointed as lead plaintiff in the lawsuit. Click here to participate in the action. The complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, the Complaint alleges that Defendants failed to disclose to investors: (1) that Hims was engaged in the 'deceptive promotion and selling of illegitimate, knockoff versions of Wegovy® that put patient safety at risk;' (2) that, as a result, there was a substantial risk that the Company's collaboration with Novo Nordisk would be terminated; and (3) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. Additionally, the Complaint alleges that Defendants made false and/or misleading statements, as well as failed to disclose material facts, including that: (1) the communication between Hims and the pharmaceutical company Novo Nordisk A/S ('Novo') would facilitate a long-term collaboration that would ensure continued access to the weight-loss drug Wegovy for Hims subscribers; (2) Novo approved of Hims' offerings of compounded semaglutide products under the 'personalization' exception; (3) branded Wegovy would be offered alongside compounded semaglutide options on the Hims platform, thereby expanding user choice; and (4) Defendants made positive statements abou the Novo partnership and Hims users' ongoing access to Wegovy alongside compounded semaglutide products. If you purchased or otherwise acquired Hims & Hers shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at [email protected], telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you. About Bragar Eagel & Squire, P.C.: Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit . Attorney advertising. Prior results do not guarantee similar outcomes. Follow us for updates on LinkedIn, X, and Facebook, and keep up with other news by following Brandon Walker, Esq. on LinkedIn and X. Contact Information: Bragar Eagel & Squire, Walker, Passmore, Esq.(212) 355-4648 [email protected]
Yahoo
17 hours ago
- Yahoo
Canaccord Genuity Initiates 'Buy' on Gold Fields (GFI) with $33 Target
Gold Fields Limited (NYSE:GFI) is one of the best stocks to buy amid gold rally. On July 28, Canaccord Genuity issued a 'Buy' rating as it initiated coverage on Gold Fields; it set the target price at $33. The investment bank cited strong near-term growth prospects for the South Africa-headquartered company. Gold Fields, a top-10 global gold producer operating 10 mines worldwide, is poised for near-term growth driven by expansions at Salares Norte and Gruyere through 2026, alongside ongoing development at Windfall and key assets like St Ives, South Deep, and Tarkwa through 2028. Canaccord Genuity projects notable deleveraging by 2027, which could bolster the company's capacity for M&A and support a re-rating of its shares through rising production, profits, and shareholder returns. Gold Fields Limited (NYSE:GFI) is a globally diversified gold mining company. It explores for, develops, and produces gold, with additional activities in copper and silver extraction. The company operates nine mines across South Africa, Australia, Ghana, Chile, and Peru, and owns the Windfall Project in Québec, Canada. Its primary product is gold bullion, refined from both underground and surface mining operations. While we acknowledge the potential of GFI as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
17 hours ago
- Yahoo
BMO Capital Resumes SSR Mining (SSRM) Coverage with $13.50 Target
SSR Mining Inc. (NASDAQ:SSRM) is one of the best stocks to buy amid gold rally. On July 18, BMO Capital Markets resumed coverage on SSR Mining with a 'Market Perform' rating and set a price target of $13.50. The firm cited SSR Mining's strong financial position, including a current ratio of 3.95 and operating with moderate debt levels. SSR Mining's cash flow is robust, supported by its gold-producing assets: the Marigold mine in Nevada and the recently acquired CC&V mine in Colorado. This positions the company as the third-largest gold producer in the United States, according to BMO. Despite these strengths, BMO expects SSR Mining shares to remain discounted relative to peers mainly due to concerns stemming from the leach pad slip and the resulting suspension at the company's Çöpler mine in Türkiye. The firm noted that a potential restart at Çöpler could improve SSR Mining's valuation but expressed that the market will likely remain cautious until there is more clarity on this issue. SSR Mining Inc. (NASDAQ:SSRM) is a precious metals mining company focused on gold production. It operates mines and development projects in the United States, Türkiye, Canada, and Argentina. Key assets include the Marigold mine in Nevada, the Seabee gold operation in Saskatchewan, and the Puna silver mine in Argentina. SSR Mining also holds a 50% interest in the Çöpler gold mine in Türkiye. While we acknowledge the potential of SSRM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
